Ansari, Habib R <br/><br/>
Involvement of COX-1 in A3 adenosine receptor-mediated contraction through endothelium in mice aorta.  [electronic resource] 

 -  American journal of physiology. Heart and circulatory physiology  Dec 2007 
 - H3448-55 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>0363-6135 
<br/><br/><label>Standard No.: </label>10.1152/ajpheart.00764.2007  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenosine--analogs & derivatives<br/>Animals<br/>Aorta--drug effects<br/>Benzofurans--pharmacology<br/>Blotting, Western<br/>Cyclooxygenase 1--metabolism<br/>Cyclooxygenase Inhibitors--pharmacology<br/>Dose-Response Relationship, Drug<br/>Endothelium, Vascular--drug effects<br/>Indomethacin--pharmacology<br/>Membrane Proteins--antagonists & inhibitors<br/>Mice<br/>Mice, Inbred BALB C<br/>Mice, Knockout<br/>Nitrobenzenes--pharmacology<br/>Polymerase Chain Reaction<br/>Pyrazoles--pharmacology<br/>Pyridines--pharmacology<br/>RNA, Messenger--metabolism<br/>Receptor, Adenosine A3--deficiency<br/>Receptors, Thromboxane--metabolism<br/>Signal Transduction--drug effects<br/>Sulfonamides--pharmacology<br/>Thromboxane B2--metabolism<br/>Thromboxane-A Synthase--antagonists & inhibitors<br/>Vasoconstriction--drug effects<br/>Vasoconstrictor Agents--pharmacology